Why Lift?

Why lift with RESTYLANE®?

Our facial bones give shape and structure to our face. As we age, bone resorption increases, leading to loss of definition and contours, especially at the posterior part of the jawline. Another consequence of aging is volume loss in the mid face, which could lead to flat cheeks, saggy skin and jowling. Creating a lift with RESTYLANE® will compensate for these changes. Another reason for lift with RESTYLANE® could be that you have a desire to enhance your facial features and bring out your individuality, no matter your age.

Restylane® DEFYNE and Restylane® LYFT can be tailored to any individual look to give you the freedom to be original. Restylane® LYFT is our firmest dermal filler and is suited for lifting the cheeks, enhancing the jawline or chin, or reducing the appearance of wrinkles.2 If you have a thinner tissue coverage, Restylane® DEFYNE could be preferred as it is slightly softer and more flexible.

Treatments with Restylane® DEFYNE last up to at least 1 year.3 Restylane® LYFT lasts up to at least 24 months with one retreatment.4

The Galderma aesthetics range, Why lift with a Restylane Lyft treatment
Treatment areas

RESTYLANE® treatment areas

Restylane® DEFYNE and Restylane® LYFT are dermal fillers that give precise results, creating a projection or a lift of the treated area. Areas that can be treated are, for example, the chin, jawline, cheeks and nose bridge.

“I have patients that look the same or better now than they did 15 years ago.”  Steven Weiner, Plastic Surgeon, USA

The Galderma aesthetics range, Restylane Lyft - Treatment areas
JAWLINE
CHEEKS
NASOLABIAL FOLDS
MARIONETTE LINES
CHIN

RESTYLANE® treatment areas

The Galderma aesthetics range, Restylane Lyft - Treatment areas
MARIONETTE LINES
CHIN
CHIN
CHEEKS
NASOLABIAL FOLDS

Restylane® DEFYNE and Restylane® LYFT are dermal fillers that give precise results, creating a projection or a lift of the treated area. Areas that can be treated are, for example, the chin, jawline, cheeks and nose bridge.

“I have patients that look the same or better now than they did 15 years ago.”  Steven Weiner, Plastic Surgeon, USA

Your treatment

Your RESTYLANE® treatment

A treatment with RESTYLANE® takes approximately 15-45 minutes, depending on the area that will be treated. Sometimes you might need a touch-up treatment about two weeks after the initial treatment to optimize your results. Most RESTYLANE® fillers contain a local anesthetic, lidocaine, that takes away most of the discomfort during treatment.

Immediately after your dermal filler treatment, you may experience some post-treatment side effects, such as redness, swelling, pain, bruising or tenderness at the treatment site. These side effects usually disappear within one week after injection. Though fillers are minimally invasive, they still carry some risks. Before the treatment, you should discuss all possible risks and benefits with your healthcare practitioner.
 

Restylane gives you long-lasting but non-permanent results, meaning that you can continuously refine your looks. 

The Galderma aesthetics range, Restylane Lyft - Your treatment
How it works

How it works

Hyaluronic acid is a substance that has a unique ability to bind water. Hyaluronic acid occurs naturally in our bodies and in all layers of our skin. It keeps our body tissues soft, hydrated and flexible. However, as we age, the body’s ability to produce hyaluronic acid lessens, leading to dry and thinner skin and loss of youthful volume.
 

Native hyaluronic acid in the body degrades quickly, in one to two days. To make the hyaluronic acid in Restylane® DEFYNE and Restylane® LYFT last longer—for up to at least a year or even two years for Restylane® LYFT with one retreatment5 —Galderma has used stabilization technologies that delay degradation. Restylane® DEFYNE and Restylane® LYFT contain hyaluronic acid gels that provide good support to maintain structure and projection.

Restylane®  was the first ever non-animal stabilized hyaluronic acid filler, when it was launched in 1996. It has become the gold standard of dermal fillers and is the injectable filler that every other filler brand is compared with.

How it works

Before & After

See how Restylane® LYFTand Restylane® DEFYNE™ can help.

Before and after

96 %

thought Restylane® LYFT met
or exceeded expectations6

9  out of  10

patients would have
Restylane® DEFYNE again7

Proven aesthetic results with
RESTYLANE® since

1996

What to ask your practioner

Here are a few questions that we recommend you to ask your healthcare practitioner: 

  • What results can I expect from the treatment?
  • What happens during the treatment?
  • Could my medical history or previous treatments affect or prevent treatment?
  • Are there any side effects and precautions that I should know about?
  • Is there anything I should do before and after treatment?
  • Any other question you may have.

You will also find detailed information about treatment with Restylane fillers in our FAQ section below.

The Galderma aesthetics range, Restylane Lyft - what to ask before a treatment

Frequently asked questions

A treatment with Restylane does not take long. Depending on the area and indication, it takes approximately 15-45 minutes. A touch-up treatment is sometimes performed approximately two weeks after the initial treatment to optimize the results.

Some people may experience mild discomfort. Most Restylane fillers contain an integrated local anesthetic, lidocaine, to provide you with a more comfortable treatment experience. You and your healthcare practitioner may decide whether additional pain relief is needed.

Ask your healthcare practitioner if you will benefit from treatment with any of the hyaluronic acid products within the Restylane range. It is important when discussing your medical history to tell your practitioner everything, including all medicines that you are taking, any present and past allergies and their seriousness, and all current or past medical conditions you have had. Your practitioner will discuss potential side effects from the injection of Restylane and how serious they may be. You should also inform your practitioner if you have received previous aesthetic treatments, both surgical and non-surgical. 

Patients with a known allergy to hyaluronic acid based products should not undergo treatment, nor should patients with bleeding disorders, or active skin disease such as inflammation, infection or tumors in or near the area to be treated. Discuss contraindications, warnings and precautions with your healthcare practitioner before Restylane filler treatments.

The Restylane products have not been tested in pregnant or breastfeeding women and is therefore not recommended if you are pregnant or breastfeeding.

After the treatment you will receive post-treatment guidelines. It is normal to experience some post-treatment discomfort, such as redness, swelling, pain, itching, bruising or tenderness at the treatment site. These side effects generally disappear within one week after injection.

Other potential side effects can occur with dermal fillers based on hyaluronic acid. You should discuss the potential treatment risks with your healthcare practitioner. Following treatment, there is sometimes a need for a touch-up treatment to achieve an optimal result.

Our portfolio of products

Image
Galderma | Aesthetics range, Restylane, botulinum toxin

Relax

Relax the tension of facial muscles associated with crow´s feet and frown lines to show how you truly feel inside.

Image
REFRESH PORTFOLIO IMAGE

Refresh

Refresh your skin from within with a boost of deep hydration, for a refreshed and vibrant look that lasts.

Image
The Galderma aesthetics range, Sculptra

Renew

Renew the structure of your skin with a collagen activator that gradually builds the foundation of the youthful, firmer you.

Are you looking for a clinic?

References

  1. Data on file (MA-39364).; Weiss RA et al. Dermatol Surg 2016;42:699–709.; Narins RS et al. Dermatol Surg 2011;37:644–650.
  2. Kablik J et al. Dermatol Surg 2009;35(Suppl1):302–312.; Weiss RA et al. Dermatol Surg 2016;42:699–709.; Narins RS et al. Dermatol Surg 2011;37:644–650.
  3. Ascher B et al. Dermatol Surg 2017;43:389–395.
  4. Data on file (MA-39364).
  5. Ascher B et al. Dermatol Surg 2017;43:389–395.; Data on file (MA-39364).
  6. Data on file (MA-39364).
  7. Cartier et al. J Drugs Dermatol. 2012 Jan;11(1 Suppl):s17-26.; Talarico S et al. Dermatol Surg 2015;41:1361–1369.